KR910006219A - 벤즈아닐리드 유도체 및 그의 제조방법 - Google Patents

벤즈아닐리드 유도체 및 그의 제조방법 Download PDF

Info

Publication number
KR910006219A
KR910006219A KR1019900015212A KR900015212A KR910006219A KR 910006219 A KR910006219 A KR 910006219A KR 1019900015212 A KR1019900015212 A KR 1019900015212A KR 900015212 A KR900015212 A KR 900015212A KR 910006219 A KR910006219 A KR 910006219A
Authority
KR
South Korea
Prior art keywords
group
formula
compound
phenyl
benzamide
Prior art date
Application number
KR1019900015212A
Other languages
English (en)
Inventor
윌리엄 브릿지 앤드류
Original Assignee
원본미기재
로오느-푸우랜크 상뜨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 로오느-푸우랜크 상뜨 filed Critical 원본미기재
Publication of KR910006219A publication Critical patent/KR910006219A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40Acylated substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40Y being a hydrogen or a carbon atom
    • C07C323/41Y being a hydrogen or an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/63Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/192Radicals derived from carboxylic acids from aromatic carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

내용 없음

Description

벤즈아닐리드 유도체 및 그의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (12)

  1. 하기 일반식(I)의 벤즈아닐리드 유도체:
    여기에서 R1은 임의적으로 하나 이상의 탄소-탄소 이중 또는 삼중 결합을 함유하고 임의적으로 하나 이상의 헤테로 원자가 사이에 끼는 C4-18-직쇄 또는 분지쇄 알킬기이며;R2는 수소, 메틸, 또는 에틸이고;R3는 할로겐원자 또는 C1-5의 직쇄 또는 분지쇄 알킬기이거나 화학식 -OY 또는 -SOnY의 기이거나 디메틸 아미노기이며;R4및 R5는 각각 독립적으로 수소, 임의적으로 하나이상의 탄소-탄소 이중 또는 삼중결합을 함유하는 C1-6의 직쇄 또는 분지쇄 알킬기 또는 화학식 -(CH2)m-Z의 기이며 여기에서 (i) Z는 화학식 -OCH3, SOqCH3또는 -N(CH3)2의 기 또는 C1-3의 알카노일아미노기이고 m은 2,3 또는 4이거나; 또는 ii)Z는 헤테로 시클릴기이고 m은 0,1,2,3 또는 4이고;X는 산소 원자 또는 화학식 -OCH2-, -SOP-,-SOPCH2-, 또는, -NR6-의 기이고;R6은 수소, 메틸, 또는 에틸, 또는 아실기이고;Y는 C1-4의 직쇄 또는 분지쇄 알킬기이고;n,p 및 q는 각각 독립적으로 0,1 또는 2이다.
  2. 제1항에 있어서, R1이 C4-18의 직쇄 또는 분지쇄 알킬 또는 알케닐기이고;R3는 C1-5의 직쇄 또는 분지쇄 알킬기이거나 화학식 -OY 또는 -SOnY의 기이거나 또는 디메틸아미노기이며;R4및 R5는 Z이 알카노일아미노 이외의 것이라는 것만을 제외하고는 전술한 바와 같으며, R2,X,R6,Y,n,p 및 q는 제1항에서 정의한 바와 같은 화합물.
  3. 제1항 또는 제2항에 있어서, R1을 정의하는데 있어서의 헤테로 원자가 산소 황 또는 질소인 화합물.
  4. 제1항 내지 제3항중 어느 한항에 있어서, R3를 정의하는데 있어서의 할로겐 원자가 염소 또는 불소인 화합물.
  5. 제1항 내지 제4항중 어느 한항에 있어서, Z이 임의적으로 하나이상의 C1-4알킬기를 함유하고, 질소, 산소 및 황으로 부터 선택한 적어도 하나의 원자를 포함하며 고리내에 C5-8을 함유하는 헤테로시클릴 기인 화합물.
  6. 제1항 내지 제5항중 어느 한항에 있어서, R6으로 표시되는 아실기가 임의적으로 하나이상의 할로겐 원자로 치환된 C2-4의 알카노일 기인 화합물.
  7. 제1항 내지 제6항중 어느 한 항에 있어서, Z로 표시되는 헤테로시클릴기가, 임의적으로 하나 또는 두개의 메틸 또는 에틸기를 함유하는, 피리딜, 푸릴, 티아디아졸일, 모르폴리닐, 피페리디닐, 이소티아졸일 또는 피롤리디닐인 화합물.
  8. 제1항 내지 제7항중 어느 한항에 있어서, 하기 특성(1)-(6)중 하나 이상을 나타내는 화합물:
    (1)R1이 C5-16의 알킬기이고; (2)R2가 수소이고; (3)R3가 메톡시 또는 메틸티오이고; (4)R4가 소수이고; (5)R5가 (i)C1-5의 알킬기; 또는 (ⅱ)이 2 또는 3이고 Z이 메톡시 또는 메틸티오인 화학식 -(CH2)m-Z의 기이고/거나; (6)X는 산소 또는 황원자이고; 다른 부호는 제1항 내지 제7항중 어느 한 항에서 정의한 바와 같다.
  9. 제1항에 있어서, N-[2-메틸티오-5-2(메톡시에틸아미노 카르보닐)]-페닐-4-데실옥시벤즈아미드; N-(2-메틸티오-5-부틸아미노카르보닐)페닐-4-데실옥시벤즈아미드; N-[2-메틸티오에틸아미노-카르보닐] 페닐-4-데실옥시벤즈아미드; N-(2-메틸티오-5-부틸아미노카르보닐)페닐-4-데실옥시벤즈아미드; N-[2-메틸티오에틸아미노-카르보닐]페닐-4-(데실티오)벤즈아미드; N-[2-메틸티오에틸아미노-카르보닐] 페닐-4-데실옥시벤즈아미드; N-[2-메틸티오에틸아미노-카르보닐]페닐-4-노닐옥시벤즈아미드; N-(2-메톡시-5-부틸아미노카르보닐)-4-(데실티오)벤즈아미드; N-부틸-4-메틸-3-[4-(3,6,9-트옥사테실옥시 벤즈아미드)]벤즈아미드; 3-[4-(N-데실)트리플루오로아세트아미도]벤즈아미도-4-메톡시-N-(2-메틸티오에틸)벤즈아미드; 또는 3-(4-데실아미노벤즈아미도)-4-메톡시-N-(2-메틸티오에틸)벤즈아미드인 화합물.
  10. 하기 일반식(Ⅱ)의 아닐린:
    (여기에서 부호들은 제1항에서 정의한 바와 같다.)을 하기 일반식(Ⅲ)의 화합물:
    (여기에서 R1및 X는 제1항에서 정의한 바와 같으며 Z1은 할로겐 원자 또는 알콕시카르보닐옥시기이다)과 또는 하기 일반식(Ⅳ)의 안하이드라이드:
    (여기에서 R1및 X는 제1항에서 정의한 바와 같다)와 반응시키고, 임의적으로 이후에 일반식(I)의 화합물 일반식(I)의 다른 화합물로 전환시키는 것으로 구성되는, 제1항에 따르는 화합물의 제조 방법.
  11. 제약학적으로 허용가능한 희석제 또는 담체와 결합한 제1항에 정의되어 있는 일반식(I)의 벤즈 아닐리드 유도체로 구성되는 제약학적 조성물.
  12. 약제로서 사용하기 위한 제1항에 정의된 바와 같은 일반식(I)의 벤즈아닐리드 유도체.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900015212A 1989-09-27 1990-09-25 벤즈아닐리드 유도체 및 그의 제조방법 KR910006219A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB89217921 1989-09-27
GB898921792A GB8921792D0 (en) 1989-09-27 1989-09-27 New compositions of matter

Publications (1)

Publication Number Publication Date
KR910006219A true KR910006219A (ko) 1991-04-27

Family

ID=10663679

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900015212A KR910006219A (ko) 1989-09-27 1990-09-25 벤즈아닐리드 유도체 및 그의 제조방법

Country Status (24)

Country Link
US (1) US5159114A (ko)
EP (1) EP0424194B1 (ko)
JP (1) JPH03178954A (ko)
KR (1) KR910006219A (ko)
AT (1) ATE110715T1 (ko)
AU (1) AU641686B2 (ko)
CA (1) CA2026273A1 (ko)
CS (1) CS465690A3 (ko)
DD (1) DD295344A5 (ko)
DE (1) DE69012040T2 (ko)
DK (1) DK0424194T3 (ko)
ES (1) ES2058849T3 (ko)
FI (1) FI904728A0 (ko)
GB (1) GB8921792D0 (ko)
HU (1) HU207839B (ko)
IE (1) IE903448A1 (ko)
IL (1) IL95762A0 (ko)
MX (1) MX9203712A (ko)
NO (1) NO173057C (ko)
NZ (1) NZ235454A (ko)
PL (1) PL163034B1 (ko)
PT (1) PT95439A (ko)
RU (1) RU2007389C1 (ko)
ZA (1) ZA907639B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9016581D0 (en) * 1990-07-27 1990-09-12 Ici Plc Fungicides
GB9017710D0 (en) * 1990-08-13 1990-09-26 May & Baker Ltd New compositions of matter
DE4200259A1 (de) * 1992-01-08 1993-07-15 Asta Medica Ag Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung
US5534529A (en) * 1993-06-30 1996-07-09 Sankyo Company, Limited Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
GB9408185D0 (en) * 1994-04-25 1994-06-15 Fujisawa Pharmaceutical Co New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
FR2946345B1 (fr) 2009-06-05 2011-05-20 Galderma Res & Dev Nouveaux derives dioxo-imidazolidine, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
FR2946342B1 (fr) 2009-06-05 2011-06-24 Galderma Res & Dev Nouveaux derives de dioxo-imidazolidine, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
FR2946346B1 (fr) 2009-06-05 2011-05-20 Galderma Res & Dev Nouveaux derives dioxo-imidazolidine, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
FR2946340B1 (fr) 2009-06-05 2011-06-24 Galderma Res & Dev Nouveaux n-phenyl acetamie, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1438612A (en) * 1974-02-08 1976-06-09 Biorex Laboratories Ltd Glycyrrhetinic acid derivatives
AU547405B2 (en) * 1981-07-08 1985-10-17 Sanofi Amidobenzamides
US4500714A (en) * 1981-10-15 1985-02-19 Chugai Seiyaku Kabushiki Kaisha 3-Substituted-ureido-N-pyridyl benzamides
AU567140B2 (en) * 1984-01-06 1987-11-12 Shionogi & Co., Ltd. Sulphonamido-benzamide derivatives
LU86258A1 (fr) * 1986-01-21 1987-09-03 Rech Dermatologiques C I R D S Composes benzamido aromatique,leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
US4835181A (en) * 1987-02-18 1989-05-30 Eli Lilly And Company Anticonvulsant agents using cyano dimethylphenyl benzamides

Also Published As

Publication number Publication date
PT95439A (pt) 1991-05-22
DE69012040T2 (de) 1995-01-05
DE69012040D1 (de) 1994-10-06
PL287073A1 (en) 1991-11-04
FI904728A0 (fi) 1990-09-26
US5159114A (en) 1992-10-27
JPH03178954A (ja) 1991-08-02
HU906230D0 (en) 1991-03-28
DK0424194T3 (da) 1994-10-03
MX9203712A (es) 1992-07-01
PL163034B1 (pl) 1994-02-28
NZ235454A (en) 1992-04-28
IE903448A1 (en) 1991-04-10
EP0424194A2 (en) 1991-04-24
EP0424194A3 (en) 1991-09-25
DD295344A5 (de) 1991-10-31
AU6313390A (en) 1991-04-11
EP0424194B1 (en) 1994-08-31
RU2007389C1 (ru) 1994-02-15
CA2026273A1 (en) 1991-03-28
ZA907639B (en) 1991-07-31
ATE110715T1 (de) 1994-09-15
CS465690A3 (en) 1992-04-15
NO904187L (no) 1991-04-02
IL95762A0 (en) 1991-06-30
AU641686B2 (en) 1993-09-30
ES2058849T3 (es) 1994-11-01
GB8921792D0 (en) 1989-11-08
NO904187D0 (no) 1990-09-26
HUT55349A (en) 1991-05-28
NO173057B (no) 1993-07-12
NO173057C (no) 1993-10-20
HU207839B (en) 1993-06-28

Similar Documents

Publication Publication Date Title
KR900003151A (ko) 화합물
KR900012911A (ko) 흥분성 아미노산 수용기 길항질 화합물
KR930701434A (ko) 옥사졸리딘 디온 유도체
KR910004581A (ko) 신규 화합물들
KR890003731A (ko) 인돌 유도체
KR870011129A (ko) 디스타마이신 a 동족체 및 이의 제조방법
KR950704294A (ko) 축합 벤조화합물(fused benzo compounds)
KR920700202A (ko) 아크릴로일 치환된 피롤 유도체
KR950000145A (ko) 혈당저하제
KR910006219A (ko) 벤즈아닐리드 유도체 및 그의 제조방법
ES488788A0 (es) Procedimiento de preparacion de una composicion farmaceuticaen particular psicotropa.
KR960007592A (ko) 신규한 피롤로카바졸
KR870007160A (ko) 신규의 디하이드로벤조푸란-및 크로만-카복스아미드 유도체, 그것의 제조 방법 및 신경이완제로서의 사용법
KR880013886A (ko) 신규 알칸술폰아닐리드 유도체, 그의 제조방법 및 이를 함유하는 제약 조성물
KR900003177A (ko) 테트라시클릭계 우울증 치료제
KR900001673A (ko) N-치환 아미드 유도체
KR910000133A (ko) 아민
KR900003118A (ko) 술폰아미도시클로알칸화합물, 이것의 제조방법 및 이것을 함유하는 제약조성물
KR910019978A (ko) 스피로 디벤조수베란 유도체
KR900018128A (ko) 카르복스아미드 유도체
KR910015537A (ko) 신규 1-아릴술포닐-2-피페리디논 유도체, 이의 제조방법, 제조용 중간체, 의약품으로서의 용도 및 이 화합물을 함유하는 조성물
ES497823A0 (es) Un procedimiento para la preparacion de derivados de tirosi-na.
KR970006283A (ko) 신규 아민고리 화합물
YU196891A (sh) Derivati tioacid amida i krmni preparati koji sadrže iste
KR910021373A (ko) 1-페녹시카보닐-2-피롤리디논 유도체 및 향정신성 약제

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid